COMMUNIQUÉS West-GlobeNewswire

National Research Corporation to Broadcast its 2019 First Quarter Conference Call Live on the Internet
22/04/2019
Lincoln, Nebraska, April 22, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2019 first quarter earnings conference call on [...]
Chembio Diagnostics to Report First Quarter 2019 Financial Results on May 1, 2019
22/04/2019
MEDFORD, N.Y., April 22, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Eve & Co Announces Board Appointment of Alice Murphy
22/04/2019
TORONTO, April 22, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that Alice Murphy has been appointed to its Board of Directors. [...]
Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development
22/04/2019
SAN FRANCISCO, April 22, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
U.S. Food and Drug Administration Accepts Biologics License Application for Eptinezumab
22/04/2019
BOTHELL, Wash., April 22, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Gritstone Oncology Announces Proposed Public Offering of Common Stock
22/04/2019
EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq:GRTS) today announced that it has commenced an underwritten public offering of 6,500,000 shares of common stock. All of the shares [...]
Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
22/04/2019
SAN DIEGO, April 22, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (Nasdaq:TPTX), a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, today [...]
CytomX Therapeutics Appoints Elaine V. Jones, Ph.D., to Board of Directors
22/04/2019
SOUTH SAN FRANCISCO, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019
22/04/2019
PLANO, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended [...]
OrthoPediatrics Corp. Announces Licensing Partnership with CoorsTek Medical
22/04/2019
WARSAW, Ind., April 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce a [...]
Brainsway Ltd. Announces Closing of Initial Public Offering
22/04/2019
JERUSALEM, April 22, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ: BWAY and TASE: BRIN) (“Brainsway”) today announced that it has closed its initial public offering of 2,500,000 American Depositary Shares (“ADSs”), [...]
DLT Resolution Provides Shareholder Update
22/04/2019
Las Vegas, NV, April 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Data Management, Information Technology and Telecommunications [...]
Alliqua BioMedical CEO Provides Update to Shareholders
22/04/2019
LANGHORNE, Pa., April 22, 2019 (GLOBE NEWSWIRE) -- Dear Shareholder: On January 3rd, I wrote a letter updating you, our shareholders, on the status of events that I thought would affect each of you in a positive way. [...]
Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019
22/04/2019
Company management to host a webcast and conference call to provide a business update and review financial results at 8:30 a.m. ET WALTHAM, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: [...]
Chiesi and Durham Bulls Partnership Steps up to Bat for Local Charities
22/04/2019
As the season’s presenting strikeouts sponsor, Chiesi pledges to donate to three area nonprofits CARY, N.C., April 22, 2019 (GLOBE NEWSWIRE) -- Starting today, Chiesi (key-A-zee), a Cary-based specialty pharmaceutical [...]
CohBar Announces the Appointment of David Greenwood to its Board of Directors
22/04/2019
Board expansion adds significant biotechnology operational and financial expertise MENLO PARK, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]
Progyny Launches Special “This is Infertility” Podcast Episodes in Honor of National Infertility Awareness Week
22/04/2019
New York City, April 22, 2019 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, announced today the launch of a special, “This is Infertility” podcast series. The four episodes are aimed to [...]
RxGen to Deliver Multiple Presentations at Association for Research in Vision and Ophthalmology Annual Meeting
22/04/2019
NEW HAVEN, Conn., April 22, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, today announced that the company will be presenting at the Association for Research in Vision and Ophthalmology [...]
Teligent Provides Update on Orphan Drug Complete Response Letter
22/04/2019
BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development partner has filed the [...]

Pages